Cardlytics Other Liab vs Capital Surpluse Analysis

CDLX Stock

USD 1.84 0.33 21.85%

Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Other Liab and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Other Liab vs Capital Surpluse

Other Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Other Liab account and Capital Surpluse. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Cardlytics' Other Liab and Capital Surpluse is 0.18. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Other Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Cardlytics are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Other Liab i.e., Cardlytics' Other Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.18

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Other Liab

Capital Surpluse

Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Cardlytics reported Tax Provision of (1.45 Million) in 2024. Issuance Of Capital Stock is likely to rise to about 81.1 M in 2025, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	43.7M	29.5M	27.9M	18.4M
Interest Income	1.4M	3.8M	3.4M	3.3M

Depreciation And Amortization Interest Income

Cardlytics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.74	0.97	0.96	0.95	0.67	0.32	0.66	0.88	0.13	-0.54	0.17	0.74	0.97	-0.02	-0.2	0.76	0.74	0.84	0.68	-0.53	0.69	0.32	0.79	-0.22	0.29
Short Long Term Debt Total	0.74		0.71	0.72	0.61	0.14	0.57	0.4	0.72	0.56	-0.81	0.08	0.58	0.68	0.19	-0.12	0.99	0.58	0.86	0.85	-0.64	0.93	0.54	0.83	-0.23	0.19
Other Current Liab	0.97	0.71		0.99	0.9	0.62	0.31	0.53	0.88	0.22	-0.55	0.24	0.62	0.97	-0.07	-0.32	0.74	0.62	0.83	0.64	-0.48	0.65	0.33	0.77	-0.22	0.27
Total Current Liabilities	0.96	0.72	0.99		0.87	0.61	0.3	0.49	0.91	0.25	-0.58	0.35	0.58	0.97	-0.04	-0.42	0.72	0.58	0.81	0.68	-0.4	0.66	0.33	0.79	-0.3	0.21
Total Stockholder Equity	0.95	0.61	0.9	0.87		0.64	0.42	0.75	0.81	-0.06	-0.47	0.0	0.8	0.88	0.02	-0.07	0.64	0.8	0.82	0.66	-0.57	0.58	0.02	0.76	-0.15	0.45
Other Liab	0.67	0.14	0.62	0.61	0.64		-0.4	0.43	0.54	-0.27	0.12	0.22	0.39	0.74	-0.21	-0.12	0.15	0.39	0.23	0.1	-0.14	0.08	0.25	0.18	0.03	0.07
Net Tangible Assets	0.32	0.57	0.31	0.3	0.42	-0.4		0.34	0.35	0.32	-0.77	-0.31	0.45	0.17	0.46	0.09	0.57	0.45	0.73	0.74	-0.58	0.65	-0.27	0.74	-0.11	0.47
Property Plant And Equipment Net	0.66	0.4	0.53	0.49	0.75	0.43	0.34		0.35	-0.44	-0.14	-0.24	0.97	0.49	-0.12	0.3	0.43	0.97	0.51	0.33	-0.37	0.37	-0.04	0.42	-0.26	0.22
Current Deferred Revenue	0.88	0.72	0.88	0.91	0.81	0.54	0.35	0.35		0.38	-0.68	0.36	0.46	0.91	0.1	-0.51	0.71	0.46	0.83	0.77	-0.45	0.68	0.28	0.82	-0.37	0.16
Net Debt	0.13	0.56	0.22	0.25	-0.06	-0.27	0.32	-0.44	0.38		-0.75	0.31	-0.28	0.22	0.48	-0.46	0.52	-0.28	0.36	0.48	-0.23	0.64	0.51	0.52	-0.06	0.03
Retained Earnings	-0.54	-0.81	-0.55	-0.58	-0.47	0.12	-0.77	-0.14	-0.68	-0.75		-0.07	-0.31	-0.5	-0.59	0.3	-0.78	-0.31	-0.82	-0.9	0.57	-0.91	-0.24	-0.93	0.19	-0.26
Accounts Payable	0.17	0.08	0.24	0.35	0.0	0.22	-0.31	-0.24	0.36	0.31	-0.07		-0.24	0.32	-0.33	-0.86	0.01	-0.24	-0.05	-0.03	0.61	-0.02	0.34	0.04	-0.49	-0.33
Cash	0.74	0.58	0.62	0.58	0.8	0.39	0.45	0.97	0.46	-0.28	-0.31	-0.24		0.57	-0.05	0.28	0.61	1.0	0.66	0.51	-0.51	0.54	0.08	0.56	-0.24	0.23
Non Current Assets Total	0.97	0.68	0.97	0.97	0.88	0.74	0.17	0.49	0.91	0.22	-0.5	0.32	0.57		-0.04	-0.35	0.69	0.57	0.76	0.61	-0.43	0.62	0.38	0.73	-0.2	0.23
Non Currrent Assets Other	-0.02	0.19	-0.07	-0.04	0.02	-0.21	0.46	-0.12	0.1	0.48	-0.59	-0.33	-0.05	-0.04		0.07	0.15	-0.05	0.23	0.47	-0.42	0.49	-0.1	0.47	0.25	0.28
Other Assets	-0.2	-0.12	-0.32	-0.42	-0.07	-0.12	0.09	0.3	-0.51	-0.46	0.3	-0.86	0.28	-0.35	0.07		-0.05	0.28	-0.12	-0.14	-0.42	-0.13	-0.22	-0.25	0.62	0.35
Long Term Debt	0.76	0.99	0.74	0.72	0.64	0.15	0.57	0.43	0.71	0.52	-0.78	0.01	0.61	0.69	0.15	-0.05		0.61	0.88	0.81	-0.69	0.92	0.53	0.82	-0.18	0.25
Cash And Short Term Investments	0.74	0.58	0.62	0.58	0.8	0.39	0.45	0.97	0.46	-0.28	-0.31	-0.24	1.0	0.57	-0.05	0.28	0.61		0.66	0.51	-0.51	0.54	0.08	0.56	-0.24	0.23
Net Receivables	0.84	0.86	0.83	0.81	0.82	0.23	0.73	0.51	0.83	0.36	-0.82	-0.05	0.66	0.76	0.23	-0.12	0.88	0.66		0.91	-0.74	0.84	0.17	0.94	-0.18	0.38
Common Stock Shares Outstanding	0.68	0.85	0.64	0.68	0.66	0.1	0.74	0.33	0.77	0.48	-0.9	-0.03	0.51	0.61	0.47	-0.14	0.81	0.51	0.91		-0.69	0.86	0.16	0.92	-0.15	0.29
Short Term Investments	-0.53	-0.64	-0.48	-0.4	-0.57	-0.14	-0.58	-0.37	-0.45	-0.23	0.57	0.61	-0.51	-0.43	-0.42	-0.42	-0.69	-0.51	-0.74	-0.69		-0.67	-0.07	-0.65	-0.29	-0.52
Long Term Debt Total	0.69	0.93	0.65	0.66	0.58	0.08	0.65	0.37	0.68	0.64	-0.91	-0.02	0.54	0.62	0.49	-0.13	0.92	0.54	0.84	0.86	-0.67		0.46	0.91	-0.19	0.24
Non Current Liabilities Total	0.32	0.54	0.33	0.33	0.02	0.25	-0.27	-0.04	0.28	0.51	-0.24	0.34	0.08	0.38	-0.1	-0.22	0.53	0.08	0.17	0.16	-0.07	0.46		0.18	-0.14	-0.42
Capital Surpluse	0.79	0.83	0.77	0.79	0.76	0.18	0.74	0.42	0.82	0.52	-0.93	0.04	0.56	0.73	0.47	-0.25	0.82	0.56	0.94	0.92	-0.65	0.91	0.18		-0.2	0.38
Inventory	-0.22	-0.23	-0.22	-0.3	-0.15	0.03	-0.11	-0.26	-0.37	-0.06	0.19	-0.49	-0.24	-0.2	0.25	0.62	-0.18	-0.24	-0.18	-0.15	-0.29	-0.19	-0.14	-0.2		0.54
Other Current Assets	0.29	0.19	0.27	0.21	0.45	0.07	0.47	0.22	0.16	0.03	-0.26	-0.33	0.23	0.23	0.28	0.35	0.25	0.23	0.38	0.29	-0.52	0.24	-0.42	0.38	0.54

Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	422.5M	1.3B	691.2M	574.1M	392.7M	439.2M
Short Long Term Debt Total	188.1M	197.2M	235.3M	266.1M	221.7M	150.9M
Other Current Liab	70.1M	313.4M	238.5M	162.2M	95.2M	123.4M
Total Current Liabilities	81.3M	327.4M	248.9M	171.1M	149.0M	138.3M
Total Stockholder Equity	157.2M	690.7M	211.6M	134.8M	70.0M	95.9M
Other Liab	2.6M	679K	54.5M	334K	384.1K	364.9K
Net Tangible Assets	139.1M	150.4M	(190.5M)	158.1M	181.8M	190.9M
Property Plant And Equipment Net	24.6M	21.5M	12.5M	10.6M	8.9M	14.1M
Current Deferred Revenue	349K	3.3M	1.8M	2.4M	2.2M	1.4M
Net Debt	(105.1M)	(36.2M)	113.4M	174.3M	156.1M	163.9M
Retained Earnings	(394.1M)	(522.6M)	(976.6M)	(1.1B)	(1.3B)	(1.2B)
Accounts Payable	1.4M	4.6M	3.8M	4.4M	3.7M	3.2M
Cash	293.2M	233.5M	121.9M	91.8M	65.6M	112.4M
Non Current Assets Total	36.9M	905.1M	441.2M	350.2M	214.7M	227.2M
Non Currrent Assets Other	5.6M	2.4M	2.6M	2.7M	35.0M	36.7M
Other Assets	10.1M	22.6M	2.4M	2.6M	2.3M	2.2M
Long Term Debt	174.0M	184.4M	226.0M	257.6M	167.7M	136.2M
Cash And Short Term Investments	293.2M	233.5M	121.9M	91.8M	65.6M	112.4M
Net Receivables	86.6M	117.2M	120.1M	126.0M	107.1M	92.1M
Common Stock Shares Outstanding	27.2M	32.2M	33.4M	36.5M	48.4M	29.5M
Long Term Debt Total	13K	174.0M	184.4M	226.0M	260.0M	273.0M
Liabilities And Stockholders Equity	422.5M	1.3B	691.2M	574.1M	392.7M	439.2M
Non Current Liabilities Total	184.1M	245.7M	230.7M	268.2M	173.8M	205.0M
Capital Surpluse	480.6M	551.4M	1.2B	1.2B	1.4B	1.4B
Inventory	129K	110K	95K	80K	72K	68.4K
Other Current Assets	5.8M	8.1M	8.1M	6.1M	5.3M	7.5M
Other Stockholder Equity	551.4M	1.2B	1.2B	1.2B	1.4B	715.9M
Total Liab	265.3M	573.1M	479.6M	439.3M	322.7M	343.3M
Deferred Long Term Liab	8.5M	3.8M	139K	198K	178.2K	169.3K
Property Plant And Equipment Gross	24.6M	11.3M	5.9M	43.7M	18.6M	16.9M
Total Current Assets	385.6M	358.7M	250.0M	223.9M	178.0M	212.0M
Accumulated Other Comprehensive Income	(192K)	486K	5.6M	2.5M	3.6M	2.1M
Short Term Debt	9.5M	6.1M	4.9M	2.1M	47.9M	50.3M
Intangible Assets	6.7M	138.7M	73.4M	59.6M	11.4M	10.8M
Property Plant Equipment	14.3M	13.9M	21.5M	5.9M	6.8M	12.5M
Capital Lease Obligations	14.1M	12.8M	9.2M	8.5M	8.1M	7.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cardlytics Other Liab vs Capital Surpluse Analysis

Other Liab vs Capital Surpluse

Other Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Other Liab

Capital Surpluse

Cardlytics fundamental ratios Correlations

Cardlytics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardlytics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Cardlytics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Long Term Debt	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Other Current Liab
Other Current Liab	+ 0.97	Total Assets
Non Current Assets Total	+ 0.97	Total Assets
Non Current Assets Total	+ 0.97	Other Current Liab

Capital Surpluse	- 0.93	Retained Earnings
Long Term Debt Total	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.9	Retained Earnings
Other Assets	- 0.86	Accounts Payable
Net Receivables	- 0.82	Retained Earnings
Retained Earnings	- 0.81	Short Long Term Debt Total